269 related articles for article (PubMed ID: 30630325)
41. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.
Liu S; Zhao W; Lan P; Mou X
Protein Cell; 2021 May; 12(5):331-345. PubMed ID: 32601832
[TBL] [Abstract][Full Text] [Related]
42. The proteolytic activity in inflammatory bowel disease: insight from gut microbiota.
Hou JJ; Ding L; Yang T; Yang YF; Jin YP; Zhang XP; Ma AH; Qin YH
Microb Pathog; 2024 Mar; 188():106560. PubMed ID: 38272327
[TBL] [Abstract][Full Text] [Related]
43. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.
Abegunde AT; Muhammad BH; Bhatti O; Ali T
World J Gastroenterol; 2016 Jul; 22(27):6296-317. PubMed ID: 27468219
[TBL] [Abstract][Full Text] [Related]
44. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
Knox NC; Forbes JD; Peterson CL; Van Domselaar G; Bernstein CN
Am J Gastroenterol; 2019 Jul; 114(7):1051-1070. PubMed ID: 31232832
[TBL] [Abstract][Full Text] [Related]
45. [Gut microbiota: its development and relation to certain diseases].
Sepová HK; Dudík B; Bilková A
Ceska Slov Farm; 2018; 66(6):267-273. PubMed ID: 29623708
[TBL] [Abstract][Full Text] [Related]
46. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of Pediatric Inflammatory Bowel Disease.
Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
[TBL] [Abstract][Full Text] [Related]
48. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
[TBL] [Abstract][Full Text] [Related]
49. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
Yu CG; Huang Q
J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
[TBL] [Abstract][Full Text] [Related]
50. [Enteric microflora in inflammatory bowel disease patients].
Rahmouni O; Dubuquoy L; Desreumaux P; Neut C
Med Sci (Paris); 2016 Nov; 32(11):968-973. PubMed ID: 28008837
[TBL] [Abstract][Full Text] [Related]
51. The Human Gut Microbiota.
Harmsen HJ; de Goffau MC
Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
[TBL] [Abstract][Full Text] [Related]
52. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.
Larmonier CB; Shehab KW; Ghishan FK; Kiela PR
Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115
[TBL] [Abstract][Full Text] [Related]
53. The gut microbiota and inflammatory bowel diseases.
Miyoshi J; Chang EB
Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
[TBL] [Abstract][Full Text] [Related]
54. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
55. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.
Dobbs SM; Dobbs RJ; Weller C; Charlett A; Augustin A; Taylor D; Ibrahim MA; Bjarnason I
J Neurovirol; 2016 Feb; 22(1):22-32. PubMed ID: 26092111
[TBL] [Abstract][Full Text] [Related]
56. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
57. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
Ahluwalia B; Moraes L; Magnusson MK; Öhman L
Scand J Gastroenterol; 2018 Apr; 53(4):379-389. PubMed ID: 29523023
[TBL] [Abstract][Full Text] [Related]
58. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
Zhao L; Zhang S; He P
Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
[TBL] [Abstract][Full Text] [Related]
59. Dysbiosis in gastrointestinal disorders.
Chang C; Lin H
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
[TBL] [Abstract][Full Text] [Related]
60. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
Kerman DH
Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
